Reversible modulation of human factor Xa activity with phosphonate esters: media effects.

[1]  V. Garsky,et al.  Selective Inhibition of Factor Xa in the Prothrombinase Complex by the Carboxyl-terminal Domain of Antistasin* , 1998, The Journal of Biological Chemistry.

[2]  Sung-Hou Kim,et al.  Structural basis for chemical inhibition of human blood coagulation factor Xa. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  U. Sinha,et al.  Reversible acylation of factor Xa as a potential therapy for hemophilia. , 1997, Thrombosis research.

[4]  E. J. Enyedy,et al.  Modulation of human α-thrombin activity with phosphonate ester inhibitors , 1997 .

[5]  S. Hollenbach,et al.  Relative Efficacy of Active Site-Blocked Factors IXa, Xa in Models of Rabbit Venous and Arterio-Venous Thrombosis , 1997, Thrombosis and Haemostasis.

[6]  S. Krishnaswamy,et al.  Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex. , 1997, Biochemistry.

[7]  Robert Huber,et al.  X-ray Structure of Active Site-inhibited Clotting Factor Xa , 1996, The Journal of Biological Chemistry.

[8]  A. Rezaie.  Role of Residue 99 at the S2 Subsite of Factor Xa and Activated Protein C in Enzyme Specificity* , 1996, The Journal of Biological Chemistry.

[9]  E. Pryzdial,et al.  Autoproteolysis or Plasmin-mediated Cleavage of Factor Xaα Exposes a Plasminogen Binding Site and Inhibits Coagulation* , 1996, The Journal of Biological Chemistry.

[10]  E. Pryzdial,et al.  Kinetics of blood coagulation factor Xaalpha autoproteolytic conversion to factor Xabeta. Effect on inhibition by antithrombin, prothrombinase assembly, and enzyme activity. , 1996, The Journal of biological chemistry.

[11]  B. Lentz,et al.  Soluble phospholipids enhance factor Xa-catalyzed prothrombin activation in solution. , 1996, Biochemistry.

[12]  I. Kovach,et al.  Reversible modification of tissue-type plasminogen activator by methylphosphonate esters. , 1996, Bioorganic & medicinal chemistry.

[13]  D. Wolf,et al.  Procoagulant activity of reversibly acylated human factor Xa. , 1995, Blood.

[14]  G. Willems,et al.  Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar headgroup of phosphatidylserine. , 1994, Biochemistry.

[15]  Á. Bencsura,et al.  Enantioselective and reversible inhibition of trypsin and alpha-chymotrypsin by phosphonate esters. , 1994, Biochemistry.

[16]  Qinjian Zhao,et al.  Rate-determining carbonyl hydration in the intramolecular hydrolysis of phenacyl phosphonate esters : isotopic probes and activation parameters , 1993 .

[17]  R. Huber,et al.  Structure of human des(1-45) factor Xa at 2.2 A resolution. , 1993, Journal of molecular biology.

[18]  I. Kovach,et al.  Reversible modulation of serine protease activity by phosphonate esters , 1992 .

[19]  C. Esmon,et al.  The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex. , 1987, The Journal of biological chemistry.

[20]  K. Mann,et al.  Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. , 1987, The Journal of biological chemistry.

[21]  L. Mayer,et al.  Vesicles of variable sizes produced by a rapid extrusion procedure. , 1986, Biochimica et biophysica acta.

[22]  M. Bally,et al.  Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. , 1985, Biochimica et biophysica acta.

[23]  M. Kerr,et al.  Activation of bovine factor X (Stuart factor)--analogy with pancreatic zymogen-enzyme systems. , 1978, Biochemistry.

[24]  E. Davie,et al.  Activation of human factor X (Stuart factor) by a protease from Russell's viper venom. , 1977, Biochemistry.

[25]  W. J. Lennox,et al.  Synthesis, hydrolysis, and toxicity data on substituted-phenacyl p-nitrophenyl methylphosphonates , 1968 .

[26]  B. Vallee,et al.  Tetranitromethane. A reagent for the nitration of tyrosyl residues in proteins. , 1966, Biochemistry.

[27]  L. Patthy.  Modular design of proteases of coagulation, fibrinolysis, and complement activation: implications for protein engineering and structure-function studies. , 1993, Methods in enzymology.

[28]  B. Vallee,et al.  [44] Nitration with tetranitromethane. , 1972, Methods in enzymology.